Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Frank Yiannas on a new strategy to advance FDA’s food safety mission and modernize oversight of imported food

The new strategy is designed to meet four goals: preventing food safety problems in the foreign supply chain prior to entry into the U.S.; effectively detecting and refusing entry of unsafe foods at U.S. borders; responding quickly when the FDA learns of unsafe imported foods; and measuring our progress to ensure that our imported food safety program remains effective and efficient.

FDA Strategy for the Safety of Imported Food

The new strategy outlines four goals: preventing food safety problems in the foreign supply chain prior to entry into the U.S.; effectively detecting and refusing entry of unsafe foods at U.S. borders; responding quickly when the FDA learns of unsafe imported foods; and measuring our progress to ensure that our imported food safety program remains effective and efficient.

Global Threats, Collaborative Solutions – Combatting Emerging Biothreats, US Agencies Perspectives.

This video offers program leaders from within the US Centers for Disease Control and Prevention (CDC), US Department of Defense (DoD),  and US Agency for International Development (USAID) speak to their work in reducing biological threats globally.

Connell of the National Science Advisory Board for Biosecurity speaks about the future of biosecurity research, ethics

Homeland Preparedness News recently interviewed Connell about her goals for the National Institutes of Health’s National Science Advisory Board for Biosecurity (NSABB) and her current research into Global Catastrophic Biological Risks (GCBRs).

Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Anna Abram on the FDA’s new plan to advance plant, animal biotechnology innovation

The new plan advances policy priorities that the US Food and Drug Administration (FDA) will pursue to clarify their science-and-risk-based approach for product developers; avoid unnecessary barriers to future innovation in plant and animal biotechnology; and advance safety.